U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07549386) titled 'Efficacy and Safety of Etoricoxib+Diacerein in Osteoarthritis.' on April 15.
Brief Summary: The goal of this clinical trial is to learn if fixed-dose combination etoricoxib 90 mg + diacerein 50 mg capsule works to treat knee/hip osteoathritis-associated pain in adults. It will also learn about the safety of the drug. The main questions it aims to answer are:
Does etoricoxib+diacerein reduces pain intensity as per WOMAC scale after 60 days? What medical problems do participants have when taking etoricoxib 90 mg+diacerein 50 mg capsule during 60 days? Researchers will compare the test drug etoricoxib 90 mg+diacerein 50 mg capsule to...